Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population.

MLA

Pikuła, Agnieszka, et al. “Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population.” Cancers, vol. 14, no. 8, Apr. 2022, p. 1997. EBSCOhost, https://doi.org/10.3390/cancers14081997.

APA

Pikuła, A., Skórzewska, M., Pelc, Z., Mlak, R., Gęca, K., Sędłak, K., Ciseł, B., Kwietniewska, M., Rawicz-Pruszyński, K., & Polkowski, W. P. (2022). Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population. Cancers, 14(8), 1997. https://doi.org/10.3390/cancers14081997

Chicago

Pikuła, Agnieszka, Magdalena Skórzewska, Zuzanna Pelc, Radosław Mlak, Katarzyna Gęca, Katarzyna Sędłak, Bogumiła Ciseł, Magdalena Kwietniewska, Karol Rawicz-Pruszyński, and Wojciech P. Polkowski. 2022. “Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population.” Cancers 14 (8): 1997. doi:10.3390/cancers14081997.